NASDAQ : ADGM

Adagio Medical Holdings, Inc. — Company profile

Healthcare · Medical Devices · United States

Last price 0.083 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.84M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Details

NameAdagio Medical Holdings, Inc.
SectorHealthcare
IndustryMedical Devices
Employees41
Founded2011
CeoTodd Usen
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS00534B1008
Cusip00534B100
Cik2006986
Sic3841
Stock TypeCommon Stock

Key executives

NameTitle
Todd UsenChief Executive Officer and Director
Deborah KasterChief Financial Officer and Chief Business Officer
Antwan Gipson M.B.A.Senior Vice President of Manufacturing and Operations
Dr. Alex Babkin Ph.D.Chief Technical Officer
Nabil JubranChief Compliance Officer
Ilya GrigorovVice President of Global Marketing and Product Management
Marie-Claude JacquesSenior Vice President of Global Sales
Maryline CullenVice President and Corporate Controller

Contact

Address26051 Merit Circle, Suite 102, Laguna Hills, California 92653, United States
Phone949 348 1188
Websitehttps://adagiomedical.com